Vasculogenic mimicry and tumor angiogenesis

American Journal of Pathology

Volumn 156, Issue 2, 2000, Pages 361-381

  Folberg, Robert ^a   Hendrix, Mary J C ^b,c   affiliation>, Andrew J Maniotise ^b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; CANCER THERAPY; DIAGNOSTIC IMAGING; HUMAN; MICROCIRCULATION; MOLECULAR MIMICRY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TUMOR VASCULARIZATION; UVEA MELANOMA;

EID: 0033840389     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64739-6     Document Type: Review

References (148)

1. Mechanisms of angiogenesis
2. Tumor angiogenesis: Therapeutic implications
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Tumor induction of VEGF promotor activity in stromal cells
5. Isolation of putative progenitor endothelial cells for angiogenesis
6. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
7. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
8. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch - A rose by any other name?
9. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: A matched case-control study
10. The prognostic value of tumor blood vessel morphology in primary uveal melanoma
11. Tumor progression in ocular melanomas
12. The biology of haematogenous metastasis in human uveal malignant melanoma
13. Fine needle aspiration biopsy in the diagnosis of intraocular cancer cytologic-histologic correlations
14. Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture
15. Fine needle aspiration biopsy in selecting treatment for inconclusive intraocular disease
16. The art and science of cytopathology
17. Fine-needle aspirates of uveal melanomas and prognosis
18. Cytomorphometry of uveal melanoma. Comparison of fine needle aspiration biopsy samples with histologic sections
19. Choroidal malignant melanoma associated with a melanocytoma
20. Metastatic uveal melanoma: Diffuse hepatic metastasis in a patient with concurrent normal serum enzyme levels and liver scan
21. Prognostic parameters in uveal melanoma: A review
22. Primary melanocytic lesions of the rabbit choroid following topical application of 7, 12-dimethylbenz[a]anthracene: Preliminary observations
23. Malignant melanoma in transgenic mice
24. Characterization of intraocular tumors arising in transgenic mice
25. Transgenic mice with pigmented intraocular tumors: Tissue of origin and treatment
26. Pigmented uveal tumours in a transgenic mouse model
27. Neoplasms of the retinal pigment epithelium: The 1998 Albert Ruedemann Sr, Memorial Lecture
28. Junctional and compound pigmented nevi induced by 9, 10-dimethyl-1,2-benzanthracene in skin of albino guinea pigs
29. Nevi and melanoma induced by chemical carcinogens in laboratory animals: Similarities and differences with human lesions
30. Skin melanoma induced by 7, 12-dimethylbenzanthracene in albino guinea pigs and its similarities to skin melanomas of humans
31. Clinicopathologic spectrum of primary uveal melanocytic lesions in an animal model
32. Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body
33. Tumours acquire their vaculature by vessel incorporation not vessel ingrowth
34. Immunohistochemical staining followed by bleaching of melanin: A practical method for ophthalmic pathology
35. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology
36. The microcirculation of choroidal and ciliary body melanomas
37. Histologic findings and prognosis of uveal malignant melanoma in Japanese patients
38. Uveal melanoma: Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type and tumor size
39. Diffuse malignant melanomas of the uvea. A clinico-pathologic study of 39 patients
40. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma
41. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas
42. Relative importance of quantifying area and vascular patterns in uveal melanoma
43. Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas
44. Microvessel count predicts survival in uveal melanoma
45. Re-assessment of the PAS patterns in uveal melanoma
46. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
47. Discussion of paper by Foss et al
48. Reassessment of the PAS patterns in uveal melanoma - Reply
49. The properties of intratumoral blood flow as a possible prognostic index in uveal melanoma - A study using color Doppler imaging
50. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid: A comparative histopathologic and ultrastructural study
51. Three-dimensional relationships between tumor cells and microcirculation using double cyanine-immunolabeling, laser scanning confocal microscopy and computer-assisted reconstruction: An alternative to cast corrosion preparations
52. Indocyanine-green videoangiography of malignant melanomas of the choroid using the scanning laser ophthalmoscope
53. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy
54. Evaluation of microvascularization pattern visibility in human choroidal melanomas: Comparison of confocal fluorescein with indocyanine green angiography
55. Reassessment of the PAS patterns in uveal melanoma - Reply
56. Retinoblastoma: The relationship of proliferating cells to blood vessels
57. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma
58. Rubeosis iridis in retinoblastoma: Histologic findings and the possible role of vascular endothelial growth factor in its induction
59. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation
60. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy
61. Vascular endothelial growth factor upregulation in human central retinal vein occlusion
62. Angio-tumoral complex in human malignant melanoma characterised by free laminin: Ultrastructural and immunohistochemical observations
63. Tumor microvessels in melanoma express the β-2 chain of laminin. Implications for melanoma metastasis
64. Expression of type VI collagen in uveal melanoma: Role in pattern formation and tumor progression
65. Biologic determinants of uveal melanoma metastatic phenotype - Role of intermediate filaments as predictive markers
66. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF)
67. Tumour vascularity is not a prognostic factor for cutaneous melanoma
68. Glycogen-rich malignant melanomas and glycogen-rich balloon cell malignant melanomas - Frequency and pattern of PAS positivity in primary and metastatic melanomas
69. The vascularity of cutaneous melanoma: A quantitative histological study of lesions 0.85-1.25 mm in thickness
70. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
71. Quantification of vascularity in nodular melanoma and spitzs nevus
72. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases
73. The vascularity of primary cutaneous melanoma
74. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: Correlation with tumour behaviour
75. Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives
76. Prognostic value of tumour vascularity in primary melanoma
77. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma
78. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma
79. Tumor angiogenesis in advanced stage ovarian carcinoma
80. Quantification of angiogenesis in solid human tumours - An international consensus on the methodology and criteria of evaluation
81. Tumoral vascularity as a prognostic factor in cancer patients - The evidence continues to grow
82. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer
83. Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma
84. Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma - Results of a multiparametric study
85. Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations
86. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin
87. Prognostic significance of microvessel density in lymph node negative breast carcinoma
88. Angiogenesis as a prognostic marker in early head and neck cancer
89. Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?
90. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB
91. Microvessel density in renal cell carcinoma: Lack of prognostic significance
92. Angiogenesis in invasive breast carcinoma: Is it associated with parameters of prognostic significance?
93. Angiogenesis in malignant fibrous histiocytoma
94. Angiogenesis in invasive squamous cell carcinoma of the lip: Tumor vascularity is not an indicator of metastatic risk
95. Microvessel count: An indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma
96. Prognostic significance of the microvascular count in colorectal cancer
97. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast
98. Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus
99. Proliferation index and vascular density of giant cell tumors of bone: Are they prognostic markers?
100. Relationship between vascularity, age and survival in non small-cell lung cancer
101. Angiogenesis: Oral c, aquamous ml, metastases, outcomes: Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma - A clinical-pathologic correlation
102. Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary
103. Relationships between different measurements of vascularity and clinico-pathological parameters in breast cancer
104. Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas
105. Independent prognostic importance of microvessel density in endometrial carcinoma
106. Angiogenesis in esophageal squamous cell carcinoma
107. Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome
108. Malignant melanoma of the choroid of a peculiar cavernous type: Clinical manifestation by hemorrhage of the vitreous body
109. Vessels of intraocular malignant melanomas
110. Impact of fibroblast growth factor-2 on tumor microvascular architecture: A tridimensional morphometric study
111. The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis
112. The growth of the blood supply to melanoma transplants in the hamster cheek pouch
113. Blood flow influences vascular growth during tumour angiogenesis
114. Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients
115. Heterogeneity and reproducibility of microvessel counts in breast cancer
116. Comparison of microscopic vascularity in benign and malignant prostate tissue
117. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma
118. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
119. Angiogenesis and regressing cutaneous malignant melanoma
120. Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice
121. Human prostate tumor angiogenesis in nude mice - Metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells
122. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
123. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor
124. Phenotype and morphology of tumor lymphatic vessels in horizontal and vertical growth phase melanoma: An immuno-electronmicroscopical study
125. Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma
126. Orthotopic models are necessary to predict therapy of transplantable tumors in mice
127. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
128. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
129. Angiostatin: A novel anglo genesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
130. Endostatin-an endogenous inhibitor of angiogenesis and tumor growth
131. Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography
132. Gross examination of eyes removed for ciliary body or choroidal melanoma
133. Klinische Darstellung der Tumor-Mikrovaskularisation beim uvealen malignen Melanom
134. Acoustic biopsy as a means for characterization of intraocular tumors
135. Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death
136. Ultrasonic tissue characterization of uveal melanoma and prediction of patient survival after enucleation and brachytherapy
137. Correlation of microcirculation architecture with ultrasound parameters of uveal melanoma
138. Correlation of ultrasound parameter imaging with microcirculatory patterns in uveal melanomas
139. The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor
140. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis
141. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot
142. Organized type I collagen influences endothelial patterns during 'spontaneous angiogenesis in vitro': Planar cultures as models of vascular development
143. Gelatinolytic metalloproteinase secretion patterns in ocular melanoma
144. The Ashton Lecture: Uveal melanoma: The past, the present and the future
145. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein - A new prognostic marker in uveal melanoma?
146. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?
147. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascuiar invasion?
148. Trophoblast pseudo-vasculogenesis: Faking it with endothelial adhesion receptors